Placeholder Banner

BIO’s Dr. Michelle McMurry-Heath Congratulates President-Elect Biden & Other Newly Elected Leaders of Both Parties Who Won

Statement from Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO):

November 7, 2020
Media Contact
Brian Newell
202.312.9268

"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records. 
 
"At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes 2020, and while we certainly did not pick sides or endorse any candidates, I’m extremely gratified that the companies of the biotechnology innovation organization made a tremendous effort to make registering and voting as easy as possible for their employees.
 
"I want to congratulate all of the election winners of both parties across the country. I’d like to congratulate President-elect Joe Biden and his running mate Vice President-elect Kamala Harris on their win. I pledge that BIO will work hard with your administration and the new Congress.
 
“For many years, President-elect Biden has championed a ‘cancer cure moonshot’ and I’m happy to report dozens of our companies are already working around the clock on this fight and other diseases starting with COVID. Biotech companies have mounted an unprecedented response to the novel Coronavirus, and have in development more than 800 vaccines or treatments already. 
 
"In addition, we look forward to working with all elected officials and hope to have an open dialogue on how we can best use biotech to reduce greenhouse gas for our planet and ending food deserts in communities all over the country.
 
"America faces many challenges and has many opportunities. On behalf of the 1,000 member companies of BIO and the nearly two million people who work in the biotech industry, I want to congratulate all the newly elected officials across the United States, and we know that if we work together our scientists will continue to lead the world.”

Discover More
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…
July 17, 2024 – BIO President and CEO John F. Crowley today released the following statement after the U.S. Food & Drug Administration (FDA) announced a plan to establish a Rare Disease Innovation Hub that will utilize new and collaborative…